您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:Health Catalyst Inc 2024年度报告 - 发现报告

Health Catalyst Inc 2024年度报告

2025-02-26美股财报喜***
AI智能总结
查看更多
Health Catalyst Inc 2024年度报告

Form 10-K_______________ (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ofincorporation or organization)(I.R.S. EmployerIdentification Number) 10897 South River Front Parkway #300South Jordan, UT 84095(801) 708-6800(Address, including zip code, and telephone number, including area code, of registrant’s principal executive Securities registered pursuant to Section 12(b) of the Act: The Nasdaq Global Select Market Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the SecuritiesAct. Yes☐No ý Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of theAct. Yes☐No ý Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant wasrequired to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the registrant was required to submit such files). Yes☐No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Accelerated Filer☐Emerging growth company☐Non-accelerated Filer☐Smaller reporting company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessmentof the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect correction of an error to previously issued financialstatements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recoveryperiod pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes The aggregate market value of the common stock held by non-affiliates of the registrant as of June 30, 2024, the lastbusiness day of the registrant’s most recently completed second fiscal quarter, was approximately $369.0 millionbased on the closing price of a share of common stock on June 30, 2024 as reported by the Nasdaq Global SelectMarket, or Nasdaq, for such date. As of February 18, 2025, the Registrant had 70,210,651 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates information by reference from the registrant’s definitive proxy statement to be filed with theSecurities and Exchange Commission pursuant to Regulation 14A, not later than 120 days after the end of the fiscalyear covered by this Annual Report on Form 10-K, in connection with the registrant’s 2025 Annual Meeting ofStockholders. Table of Contents Item 1.Business5Item 1A.Risk Factors25Item 1B.Unresolved Staff Comments58Item 1C.Cybersecurity59Item 2.Properties60Item 3.Legal Proceedings60Item 4.Mine Safety Disclosures60PART II.Item 5.Market for Registrant’s Common Equity, Related Stockholders Matters, andIssuer Purchases of Equity Securities61Item 6.[Reserved]62Item 7.Management’s Discussion and Analysis of Financial Condition and Results ofOperations63Item 7A.Quantitative and Qualitative Disclosures About Market Risk88Item 8.Consolidated Financial Statements and Supplementary Data91Item 9.Changes in and Disagreements with Accountants on Accounting and FinancialDisclosure141Item 9A.Controls and P